EML4 and non-small cell lung carcinoma: The FISH assay performed in this study is the FDA-approved companion diagnostic for the NSCLC crizotinib, which uses probes that target to ALK locus on chromosome 2p23, thus recognizing all ALK gene rearrangements including non-EML4-ALK fusion partners.